Clinically mild encephalitis/encephalopathy with a reversible splenial lesion.
Shiihara
Takashi
T
Kato
Mitsuhiro
M
Hayasaka
Kiyoshi
K
D000293:Adolescent; D001928:Brain Diseases, Metabolic / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D003337:Corpus Callosum / Q000473:pathology* / Q000503:physiopathology; D004272:DNA, Mitochondrial / Q000235:genetics; D003937:Diagnosis, Differential; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D015850:Interleukin-6 / Q000134:cerebrospinal fluid; D019344:Lactic Acid / Q000134:cerebrospinal fluid; D008279:Magnetic Resonance Imaging / Q000592:standards; D028361:Mitochondrial Diseases / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D025261:Mitochondrial Proton-Translocating ATPases / Q000235:genetics; D009154:Mutation / Q000235:genetics*
D004272:DNA, Mitochondrial; D007166:Immunosuppressive Agents; D015850:Interleukin-6; D019344:Lactic Acid; C412204:ATP synthase subunit 6; D025261:Mitochondrial Proton-Translocating ATPases; D005472:Fluorouracil